NCT06912230 Hypoxia, Appetite, and Energy Intake in Young Female Adults
| NCT ID | NCT06912230 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ottawa |
| Condition | Hypoxia |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-11-13 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-11-13 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effects of acute passive continuous hypoxemia (simulated high-altitude at rest) on appetite and energy intake in healthy young female adults. The main questions it aims to answer are: * Does six hours of simulated high-altitude (5000 meters) reduce scores of subjective appetite and energy intake? * Do changes in appetite and energy intake persist in the hours following the end of hypoxic exposure? Researchers will compare the effects of simulated high-altitude to a control normoxia (sea-level) condition to see if exposure to low oxygen levels independently affect appetite and energy intake. Participants will: * Visit the laboratory for a preliminary screening session to assess eligibility. * Undergo two randomized, single-blind, experimental sessions consisting of six hours of passive exposure to normoxia or hypoxia in a climate-controlled chamber. * Consume foods provided from a curated list, served in ad libitum quantities, after leaving the laboratory to assess post-exposure energy intake.
Eligibility Criteria
Inclusion Criteria: * English or French speaking * Ability to provide informed consent Exclusion Criteria: * History or evidence of chronic disease * Current use of hypolipemic medication * Current use of hormonal contraceptives * Current use of antidepressants * Current use of anticoagulants * Ongoing smoking status * Experiencing pregnancy, puerperium, or irregular menstrual cycles
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06912230 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 30 Years, studying Hypoxia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06912230 currently recruiting?
Yes, NCT06912230 is actively recruiting participants. Contact the research team at imbeault@uottawa.ca for enrollment information.
Where is the NCT06912230 trial being conducted?
This trial is being conducted at Ottawa, Canada.
Who is sponsoring the NCT06912230 clinical trial?
NCT06912230 is sponsored by University of Ottawa. The trial plans to enroll 10 participants.